FOI release

RMP- Disulfiram 200mg Tablets

Case reference FOI2025/00600

Received 6 February 2025

Published 5 August 2025

Request

I would like to request a copy of the latest UK PAR for Disulfiram 200mg Tablets, Brown & Burk UK Ltd (PL 25298/0151) for RMP preparation for Aspire Pharma Limited. The safety concerns for Disulfiram 200 mg Tablets are not available at CMDh, MHRA (UK-PAR), EMA (EPAR) or any other regulatory websites. Request you to kindly share this for the RMP preparation.

Response

see attached

Documents

• FOI2025_00600 redacted for publication.pdf (114.9 KB)
• PAR.pdf (425.3 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.